Dan Leonard

Stock Analyst at RBC Capital

(4.81)
# 512
Out of 5,133 analysts
540
Total ratings
62.1%
Success rate
14.6%
Average return

Stocks Rated by Dan Leonard

Bio-Techne
Nov 10, 2026
Maintained: Hold
Price Target: $73
Current: $72.83
Upside: +0.23%
Guardant Health
Nov 6, 2026
Reiterated: Buy
Price Target: $200
Current: $158.79
Upside: +25.95%
Mettler-Toledo International
Nov 6, 2026
Reiterated: Hold
Price Target: $1,515 → $1,790
Current: $1,762.28
Upside: +1.57%
Natera
Nov 6, 2026
Reiterated: Buy
Price Target: $460
Current: $320.39
Upside: +43.58%
10x Genomics
Nov 5, 2026
Reiterated: Hold
Price Target: $70
Current: $65.05
Upside: +7.61%
Bio-Rad Laboratories
Nov 4, 2026
Reiterated: Buy
Price Target: $390 → $440
Current: $388.31
Upside: +13.31%
GRAIL
Nov 4, 2026
Rated: Hold
Price Target: $84 → $100
Current: $128.08
Upside: -21.92%
Revvity
Nov 3, 2026
Rated: Hold
Price Target: $135 → $172
Current: $160.72
Upside: +7.02%
Waters
Nov 3, 2026
Reiterated: Buy
Price Target: $475 → $525
Current: $476.70
Upside: +10.13%
Repligen
Nov 1, 2026
Reiterated: Buy
Price Target: $200
Current: $178.94
Upside: +11.77%
Reiterated: Buy
Price Target: $310
Current: $220.78
Upside: +40.41%
Rated: Hold
Price Target: $14 → $17
Current: $15.91
Upside: +6.85%
Rated: Hold
Price Target: $580 → $730
Current: $721.63
Upside: +1.16%
Reiterated: Buy
Price Target: $250 → $265
Current: $235.12
Upside: +12.71%
Reiterated: Buy
Price Target: $153 → $185
Current: $180.17
Upside: +2.68%
Rated: Hold
Price Target: $40 → $45
Current: $66.54
Upside: -32.37%
Rated: Buy
Price Target: $15 → $10
Current: $12.22
Upside: -18.17%
Reiterated: Hold
Price Target: $170 → $175
Current: $353.34
Upside: -50.47%
Reiterated: Buy
Price Target: $355 → $340
Current: $413.09
Upside: -17.69%
Reiterated: Hold
Price Target: $52
Current: $50.55
Upside: +2.87%
Reiterated: Buy
Price Target: $280 → $240
Current: $278.84
Upside: -13.93%
Reiterated: Buy
Price Target: $11 → $13
Current: $20.47
Upside: n/a
Reiterated: Buy
Price Target: $260 → $220
Current: $207.59
Upside: n/a
Reiterated: Hold
Price Target: $24 → $28
Current: $13.73
Upside: n/a
Downgraded: Sell
Price Target: $300 → $305
Current: $672.93
Upside: n/a
Reiterated: Hold
Price Target: $25 → $20
Current: $26.15
Upside: n/a
Reiterated: Hold
Price Target: $11
Current: $8.02
Upside: n/a
Reiterated: Sell
Price Target: $8 → $7
Current: $30.26
Upside: n/a
Reiterated: Buy
Price Target: $340 → $320
Current: $371.83
Upside: n/a
Reiterated: Hold
Price Target: $160 → $145
Current: $259.67
Upside: n/a
Reiterated: Buy
Price Target: $86 → $95
Current: $135.42
Upside: n/a
Initiated Coverage: Buy
Price Target: $11
Current: $0.0001
Upside: n/a
Reiterated: Hold
Price Target: $45 → $35
Current: $5.74
Upside: n/a
Initiated Coverage: Buy
Price Target: $280
Current: $215.25
Upside: n/a
Reiterated: Buy
Price Target: $7
Current: $0.01
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $84.42
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $25.92
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $110.51
Upside: n/a
Reiterated: Buy
Price Target: $4
Current: $0.000001
Upside: n/a
Reiterated: Hold
Price Target: $4.5 → $3.5
Current: $0.8007
Upside: n/a
Reiterated: Buy
Price Target: $20 → $15
Current: $0.6942
Upside: n/a